Replies to post #446377 on Anavex Life Sciences Corp (AVXL)

[Reyeton]

I thought the placebo effect was on those taking the drug during the first four weeks. No?

[D-Mike]

Good post Gary & I agree with you. Please keep posting here.

I enjoy reading your posts on the NWBO forum. I’m long on both AVXL & NWBO. I think 2024 will be significantly positive for both companies.

[Pazzo1212]

Given many of the pediatric Rett patients are from Australia, and the fact that the Rett Syndrome Association of Australia is a huge supporter of Anavex, maybe we should also go the route of the EMA for a Rett approval.

[crescentmotor]

I still believe they have a shot at a conditional approval in which they can sell the drug,

Hi Gary--great to see you here on this forum as we spent a lot of years together back on the IMGN IV board. Your first post was a good one. It offers a credible reason why AVXL did not file a Form 8-K when the EXCELLENCE top line data was released; that is, AVXL is leaving the door open for possible regulatory approval irrespective of the failed trial endpoints.